Literature DB >> 34351568

The Roles of Tetramethylpyrazine During Neurodegenerative Disease.

Zeyu Meng1, Huize Chen2, Shengxi Meng3.   

Abstract

With the aging of the world population, neurodegenerative diseases are considered crippling diseases, which seriously affect the quality of life and are an increasing burden on society and the economy. As a major alkaloid in Ligusticum chuanxiong Hort, tetramethylpyrazine (TMP) plays an increasingly significant role during neurodegenerative diseases, including roles as an anti-inflammatory, antioxidative, antiplatelet citatory poisoning, and anti-inflammation. This review focuses on the latest advances in the roles and mechanisms of action of TMP in neurodegenerative diseases to stimulate new concepts and methods for the prevention and treatment of neurodegenerative diseases.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Neurodegenerative disease; Neuroprotection; Tetramethylpyrazine

Mesh:

Substances:

Year:  2021        PMID: 34351568     DOI: 10.1007/s12640-021-00398-y

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  48 in total

1.  MicroRNAs: Roles in Regulating Neuroinflammation.

Authors:  Andrew D Gaudet; Laura K Fonken; Linda R Watkins; Randy J Nelson; Phillip G Popovich
Journal:  Neuroscientist       Date:  2017-07-24       Impact factor: 7.519

2.  Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.

Authors:  Ravi Chandra Sekhara Reddy Danduga; Subba Reddy Dondapati; Phani Kumar Kola; Lilly Grace; Rahil Vandana Bisky Tadigiri; Vijaya Kishore Kanakaraju
Journal:  Biomed Pharmacother       Date:  2018-06-22       Impact factor: 6.529

Review 3.  The Logic of the 26S Proteasome.

Authors:  Galen Andrew Collins; Alfred L Goldberg
Journal:  Cell       Date:  2017-05-18       Impact factor: 41.582

4.  A Potent Multi-functional Neuroprotective Derivative of Tetramethylpyrazine.

Authors:  Hai-Yun Chen; Da-Ping Xu; Guo-Lian Tan; Wei Cai; Gao-Xiao Zhang; Wei Cui; Jin-Zhao Wang; Cheng Long; Ye-Wei Sun; Pei Yu; Karl Wahkeung Tsim; Zai-Jun Zhang; Yi-Fan Han; Yu-Qiang Wang
Journal:  J Mol Neurosci       Date:  2015-05-17       Impact factor: 3.444

5.  Effects of miR-150 on neuropathic pain process via targeting AKT3.

Authors:  Wei Cai; Yang Zhang; Yan Liu; Hailin Liu; Zhijie Zhang; Zhen Su
Journal:  Biochem Biophys Res Commun       Date:  2019-07-31       Impact factor: 3.575

Review 6.  [Parkinson's Disease: Clinical Review and Update].

Authors:  Verónica Cabreira; João Massano
Journal:  Acta Med Port       Date:  2019-10-01

7.  A Novel Tetramethylpyrazine Derivative Protects Against Glutamate-Induced Cytotoxicity Through PGC1α/Nrf2 and PI3K/Akt Signaling Pathways.

Authors:  Haiyun Chen; Jie Cao; Zeyu Zhu; Gaoxiao Zhang; Luchen Shan; Pei Yu; Yuqiang Wang; Yewei Sun; Zaijun Zhang
Journal:  Front Neurosci       Date:  2018-08-15       Impact factor: 4.677

8.  Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson's disease models through activating the MEF2-PGC1α and BDNF/CREB pathways.

Authors:  Haiyun Chen; Jie Cao; Ling Zha; Peile Wang; Zheng Liu; Baojian Guo; Gaoxiao Zhang; Yewei Sun; Zaijun Zhang; Yuqiang Wang
Journal:  Aging (Albany NY)       Date:  2020-07-24       Impact factor: 5.682

9.  Distinct amyloid-β and tau-associated microglia profiles in Alzheimer's disease.

Authors:  Bart J L Eggen; Erik W G M Boddeke; Emma Gerrits; Nieske Brouwer; Susanne M Kooistra; Maya E Woodbury; Yannick Vermeiren; Mirjam Lambourne; Jan Mulder; Markus Kummer; Thomas Möller; Knut Biber; Wilfred F A den Dunnen; Peter P De Deyn
Journal:  Acta Neuropathol       Date:  2021-02-20       Impact factor: 17.088

View more
  2 in total

Review 1.  Multiple Roles of Paeoniflorin in Alzheimer's Disease.

Authors:  Zeyu Meng; Huize Chen; Chujun Deng; Shengxi Meng
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-11       Impact factor: 2.650

2.  Therapeutic Effects and Metabolic Spectrum of Traditional Chinese Medicine Hengqing II Prescription on Alzheimer's Disease.

Authors:  Shengxi Meng; Shaopeng Li; Huize Chen; Chujun Deng; Zeyu Meng; Yimo Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-02       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.